These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bastos AU; de Jesus AC; Cerutti JM Eur J Endocrinol; 2018 Jan; 178(1):83-91. PubMed ID: 29046324 [TBL] [Abstract][Full Text] [Related]
5. Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers. Ricarte-Filho JC; Li S; Garcia-Rendueles ME; Montero-Conde C; Voza F; Knauf JA; Heguy A; Viale A; Bogdanova T; Thomas GA; Mason CE; Fagin JA J Clin Invest; 2013 Nov; 123(11):4935-44. PubMed ID: 24135138 [TBL] [Abstract][Full Text] [Related]
6. ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Leeman-Neill RJ; Kelly LM; Liu P; Brenner AV; Little MP; Bogdanova TI; Evdokimova VN; Hatch M; Zurnadzy LY; Nikiforova MN; Yue NJ; Zhang M; Mabuchi K; Tronko MD; Nikiforov YE Cancer; 2014 Mar; 120(6):799-807. PubMed ID: 24327398 [TBL] [Abstract][Full Text] [Related]
7. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese. Liu RT; Chou FF; Wang CH; Lin CL; Chao FP; Chung JC; Huang CC; Wang PW; Cheng JT Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154 [TBL] [Abstract][Full Text] [Related]
8. Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima. Iyama K; Matsuse M; Mitsutake N; Rogounovitch T; Saenko V; Suzuki K; Ashizawa M; Ookouchi C; Suzuki S; Mizunuma H; Fukushima T; Suzuki S; Yamashita S Thyroid; 2017 Jun; 27(6):811-818. PubMed ID: 28351223 [TBL] [Abstract][Full Text] [Related]
9. Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma. Dinets A; Hulchiy M; Sofiadis A; Ghaderi M; Höög A; Larsson C; Zedenius J Eur J Endocrinol; 2012 Jun; 166(6):1049-60. PubMed ID: 22457234 [TBL] [Abstract][Full Text] [Related]
10. Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma. Guerra A; Zeppa P; Bifulco M; Vitale M Thyroid; 2014 Feb; 24(2):254-9. PubMed ID: 23806056 [TBL] [Abstract][Full Text] [Related]
11. AGK-BRAF is associated with distant metastasis and younger age in pediatric papillary thyroid carcinoma. Sisdelli L; Cordioli MICV; Vaisman F; Moraes L; Colozza-Gama GA; Alves PAG; Araújo ML; Alves MTS; Monte O; Longui CA; Cury AN; Carvalheira G; Cerutti JM Pediatr Blood Cancer; 2019 Jul; 66(7):e27707. PubMed ID: 30924609 [TBL] [Abstract][Full Text] [Related]
12. AGK-BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma. Cordioli MI; Moraes L; Carvalheira G; Sisdelli L; Alves MT; Delcelo R; Monte O; Longui CA; Cury AN; Cerutti JM Cancer Med; 2016 Jul; 5(7):1535-41. PubMed ID: 27037835 [TBL] [Abstract][Full Text] [Related]
14. Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries. Vuong HG; Kondo T; Oishi N; Nakazawa T; Mochizuki K; Inoue T; Tahara I; Kasai K; Hirokawa M; Tran TM; Katoh R Cancer Med; 2016 Aug; 5(8):1883-9. PubMed ID: 27264674 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic alterations in papillary thyroid cancers of young patients. Sassolas G; Hafdi-Nejjari Z; Ferraro A; Decaussin-Petrucci M; Rousset B; Borson-Chazot F; Borbone E; Berger N; Fusco A Thyroid; 2012 Jan; 22(1):17-26. PubMed ID: 22150560 [TBL] [Abstract][Full Text] [Related]
16. Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment. Boaventura P; Pereira D; Celestino R; Mendes A; Nakasawa T; Teixeira-Gomes J; Sobrinho-Simões M; Soares P Eur J Endocrinol; 2013 Nov; 169(5):673-9. PubMed ID: 23966419 [TBL] [Abstract][Full Text] [Related]
17. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937 [TBL] [Abstract][Full Text] [Related]
18. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAF Lee SE; Hwang TS; Choi YL; Kim WY; Han HS; Lim SD; Kim WS; Yoo YB; Kim SK Thyroid; 2017 Jun; 27(6):802-810. PubMed ID: 28293988 [TBL] [Abstract][Full Text] [Related]
19. Detection of RET rearrangements in papillary thyroid carcinoma using RT-PCR and FISH techniques - A molecular and clinical analysis. Musholt TJ; Staubitz JI; Antonio Cámara RJ; Musholt PB; Humberg D; Springer E; Schad A Eur J Surg Oncol; 2019 Jun; 45(6):1018-1024. PubMed ID: 30472213 [TBL] [Abstract][Full Text] [Related]
20. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications. Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]